ArticlebioRxiv : the preprint server for biology2025
The impact of the serotonergic psychedelic DOI on active vision in freely moving mice.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Psychedelic compounds have the ability to generate altered states of consciousness and profoundly distort perception, often resulting in visual hallucinations. While psychedelics have recently regained attention for their potential cognitive and therapeutic effects, how these drugs affect visual processing to generate visual distortions and hallucinations is not as well characterized. Furthermore, studies investigating the effect of psychedelics on visual function have all been performed using head-fixed preparations, preventing animals from engaging in the natural visual behaviors that the visual system evolved to support. To determine the impact of psychedelics on active vision, we recorded neural activity in primary visual cortex (V1) of mice during free movement, while simultaneously recording eye and head position, before and after administration of the serotonergic psychedelic DOI (2,5-dimethoxy-4-iodoamphetamine). We find that DOI increases the frequency of visual active sensing behaviors during free movement and leads to a net reduction in the visually-evoked activity that these behaviors generate in V1. The effect of DOI was highly diverse across the population of V1 neurons, driving suppression and facilitation of visual responses in a laminar specific manner. Finally, the effects of DOI were dependent upon both visual input and the statistics of the stimulus. We found a striking dissociation between impact on gaze shift responses and flashed sparse noise presented during head-fixation, which may reflect predictability of the stimulus. These findings provide insights into how psychedelics disrupt sensory processing and the neural mechanisms underlying these altered perceptual states.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.